Blockade with an anti-PD-1 antibody enhanced proliferation of T cells and thereby increased expression of IFN-γ in the tumor microenvironment which in turn increased production of CXCL10 (Interferon gamma-induced protein 10) [59]. Here, CXCL10 is linked to neoplasm.